Thomas Steyer’s Privia Health PRVA Stock Holding History

Thomas Steyer’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-74,000	Closed	-$1.93M	–	174
2023 Q2	$1.93M	Buy	+74,000	New	+$1.95M	0.01%	118

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Thomas Steyer's PRVA Position: Q3 2023 in Review

Thomas Steyer sold out of Privia Health (PRVA) in Q3 2023, closing a stake of 74,000 shares — an estimated $1.93M sold.

Thomas Steyer first reported a position in PRVA in Q2 2023 and held it in 1 quarter. The position peaked at $1.93M in Q2 2023. 218 funds tracked by Wall St. Rank hold PRVA as of Q3 2023.

Thomas Steyer reported no remaining Privia Health position as of Q3 2023 after selling out during the quarter.
Thomas Steyer sold 74,000 Privia Health shares in Q3 2023, an estimated $1.93M.
Thomas Steyer first reported a position in Privia Health in Q2 2023 and held it in 1 quarter.
Thomas Steyer's Privia Health position peaked at $1.93M in Q2 2023.
218 funds tracked by Wall St. Rank held Privia Health as of Q3 2023.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.